Valvular & structural heart disease

Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement in United States

JACC Cardiovasc IntervPublished Retrospective cohort study

Authors' conclusion

In the United States, IVL is increasingly adopted to facilitate TF TAVR. IVL TAVR patients exhibited a higher burden of comorbidities and experienced more complications compared to non-IVL TAVR patients.

Study context

Population
Patients undergoing percutaneous transcatheter aortic valve replacement (TAVR), Vizient Clinical Database, US, October 2020–November 2023
Participants
129,655 patients · 361 hospitals
Exposure
Intravascular lithotripsy (IVL) TAVR vs non-IVL TAVR
  • IVL TAVRn = 1,242
Outcome
Composite of:
  • In-hospital death
  • Stroke
  • Vascular complications
  • Surgical vascular intervention
  • Major bleeding
Follow-up
In-hospital
Methodological detailspropensity-score matched (3:1)
  • Propensity-score matched (3:1)

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

Median

OutcomeIVL TAVRnon-IVL TAVR
Elixhauser comorbidity score5 (IQR 4–7)4 (IQR 3–6)
TAVR completed via transfemoral (TF) approach (IVL TAVR)
99.7% · 1,238 of 1,242

In-hospital death and stroke

Similar in both groups

Original publication

Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement in United States. JACC Cardiovasc Interv. Published 28 October 2024. doi:10.1016/j.jcin.2024.08.033

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.